Financhill
Sell
7

PRQR Quote, Financials, Valuation and Earnings

Last price:
$1.34
Seasonality move :
1.19%
Day range:
$1.29 - $1.39
52-week range:
$1.40 - $4.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.90x
P/B ratio:
1.60x
Volume:
323.3K
Avg. volume:
595K
1-year change:
-41.92%
Market cap:
$147.3M
Revenue:
$20.5M
EPS (TTM):
-$0.34
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- $1.6M $3.8M $7.1M $20.5M
Revenue Growth (YoY) -- -- 139.96% 86.06% 190.15%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $43.6M $50M $53.6M $27.2M $39.3M
Selling, General & Admin $15.6M $20.5M $19.7M $17.6M $14.8M
Other Inc / (Exp) -$2.7M -$85.2K $6.4M $6M $365.8K
Operating Expenses $48.4M $69.3M $72.5M $44.7M $53.4M
Operating Income -$48.4M -$67.7M -$68.7M -$37.7M -$33M
 
Net Interest Expenses -- $4M $5.3M -- --
EBT. Incl. Unusual Items -$53.1M -$71.8M -$67.6M -$30.1M -$30.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $141.6K $138.4K $101.2K -$84.4K -$213.2K
Net Income to Company -$53.2M -$71.9M -$67.7M -$30M -$30M
 
Minority Interest in Earnings $56K $69.8K -$232K -$415.7K --
Net Income to Common Excl Extra Items -$53.2M -$71.9M -$67.9M -$30.4M -$30M
 
Basic EPS (Cont. Ops) -$1.06 -$1.12 -$0.95 -$0.38 -$0.35
Diluted EPS (Cont. Ops) -$1.06 -$1.12 -$0.95 -$0.38 -$0.35
Weighted Average Basic Share $50.1M $64.2M $71.6M $81M $86.1M
Weighted Average Diluted Share $50.1M $64.2M $71.6M $81M $86.1M
 
EBITDA -$48.1M -$65M -$59.5M -$26.1M -$26.1M
EBIT -$50.8M -$67.8M -$62.2M -$28.8M -$29.1M
 
Revenue (Reported) -- $1.6M $3.8M $7.1M $20.5M
Operating Income (Reported) -$48.4M -$67.7M -$68.7M -$37.7M -$33M
Operating Income (Adjusted) -$50.8M -$67.8M -$62.2M -$28.8M -$29.1M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- $251.6K $736.2K $3.5M $4.6M
Revenue Growth (YoY) -- -- 192.6% 380.37% 29.82%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $10M $14.2M $10.9M $8.3M $11.3M
Selling, General & Admin $4.2M $6.1M $3M $5.1M $4.2M
Other Inc / (Exp) -$2.2M $92.6K $5.2M $2.8M $76.8K
Operating Expenses $13.9M $19.1M $13.5M $13.4M $15.3M
Operating Income -$13.9M -$18.9M -$12.7M -$9.9M -$10.7M
 
Net Interest Expenses -- $1M $6.1M -- --
EBT. Incl. Unusual Items -$15.7M -$19.8M -$13.6M -$5.9M -$9.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $45.3K $25.2K -- $5.4K --
Net Income to Company -$14.2M -$20.7M -$16.4M -$5.8M -$9.7M
 
Minority Interest in Earnings $13.1K $21.7K $3.1K -- --
Net Income to Common Excl Extra Items -$15.8M -$19.8M -$13.6M -$5.9M -$9.9M
 
Basic EPS (Cont. Ops) -$0.31 -$0.30 -$0.18 -$0.08 -$0.10
Diluted EPS (Cont. Ops) -$0.31 -$0.30 -$0.18 -$0.08 -$0.10
Weighted Average Basic Share $50.2M $71.3M $72.5M $81.2M $99.4M
Weighted Average Diluted Share $50.2M $71.3M $72.5M $81.2M $99.4M
 
EBITDA -$15.6M -$18.3M -$5.7M -$313.4K -$6.2M
EBIT -$16.4M -$19M -$6.4M -$1.1M -$6.9M
 
Revenue (Reported) -- $251.6K $736.2K $3.5M $4.6M
Operating Income (Reported) -$13.9M -$18.9M -$12.7M -$9.9M -$10.7M
Operating Income (Adjusted) -$16.4M -$19M -$6.4M -$1.1M -$6.9M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- $3.8M $7M $20.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $43.4M $49.8M $53.6M $27.2M $39.3M
Selling, General & Admin $15.6M $20.5M $19.7M $17.6M $14.8M
Other Inc / (Exp) $7M -$249.7K $6.9M $6.1M $685.5K
Operating Expenses $58.3M $68.9M $72.7M $44.7M $53.7M
Operating Income -$58.3M -$67.4M -$68.9M -$37.7M -$33.3M
 
Net Interest Expenses -- $3.7M $5.2M -- --
EBT. Incl. Unusual Items -$53.3M -$71.7M -$67.2M -$30.1M -$30.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $145.1K $138.7K $98.7K -$85.1K -$212.1K
Net Income to Company -$53.2M -$71.9M -$67.7M -$30M -$30M
 
Minority Interest in Earnings $55.6K $69.4K -$233.2K -$417K --
Net Income to Common Excl Extra Items -$53.4M -$71.7M -$67.5M -$30.4M -$30.1M
 
Basic EPS (Cont. Ops) -$1.06 -$1.15 -$0.94 -$0.38 -$0.34
Diluted EPS (Cont. Ops) -$1.06 -$1.15 -$0.94 -$0.38 -$0.34
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$58.1M -$64.7M -$59.9M -$26.2M -$26.5M
EBIT -$60.8M -$67.5M -$62.6M -$28.9M -$29.5M
 
Revenue (Reported) -- -- $3.8M $7M $20.4M
Operating Income (Reported) -$58.3M -$67.4M -$68.9M -$37.7M -$33.3M
Operating Income (Adjusted) -$60.8M -$67.5M -$62.6M -$28.9M -$29.5M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $1.6M $3.8M $7M $20.4M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $49.8M $53.6M $27.2M $39.3M --
Selling, General & Admin $20.5M $19.7M $17.6M $14.8M --
Other Inc / (Exp) -$249.7K $6.9M $6.1M $685.5K --
Operating Expenses $68.9M $72.7M $44.7M $53.7M --
Operating Income -$67.4M -$68.9M -$37.7M -$33.3M --
 
Net Interest Expenses $4M $7M $584.3K -- --
EBT. Incl. Unusual Items -$71.7M -$67.2M -$30.1M -$30.3M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $138.8K $98.7K -$85.1K -$212.1K --
Net Income to Company -$71.9M -$67.7M -$30M -$30M --
 
Minority Interest in Earnings $69.4K -$233.2K -$417K -- --
Net Income to Common Excl Extra Items -$71.7M -$67.5M -$30.4M -$30.1M --
 
Basic EPS (Cont. Ops) -$1.15 -$0.94 -$0.38 -$0.34 --
Diluted EPS (Cont. Ops) -$1.15 -$0.94 -$0.38 -$0.34 --
Weighted Average Basic Share $256.5M $286.6M $324M $344.3M --
Weighted Average Diluted Share $256.5M $286.6M $324M $344.3M --
 
EBITDA -$64.7M -$59.9M -$26.2M -$26.5M --
EBIT -$67.5M -$62.6M -$28.9M -$29.5M --
 
Revenue (Reported) $1.6M $3.8M $7M $20.4M --
Operating Income (Reported) -$67.4M -$68.9M -$37.7M -$33.3M --
Operating Income (Adjusted) -$67.5M -$62.6M -$28.9M -$29.5M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $93.3M $212.3M $101.6M $131.5M $155.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $4.2M $3.6M $2.6M $876.6K $2.5M
Other Current Assets -- -- -- -- --
Total Current Assets $98.4M $216.8M $165.6M $133.7M $160.1M
 
Property Plant And Equipment $22.9M $19.8M $17.4M $18.7M $14.7M
Long-Term Investments $131.6K $712.2K $666K -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $121.4M $237.3M $183.7M $152.4M $174.8M
 
Accounts Payable $271.8K $216.3K $420.4K $1.7M $16.7K
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $1.4M $5.4M $2.7M -- $4.8M
Current Portion Of Capital Lease Obligations $1.5M $1.7M $1.5M $1.8M $1.6M
Other Current Liabilities $8.6M $16.7M $10.7M $9.7M $9.7M
Total Current Liabilities $12.7M $31.2M $22.5M $37.8M $40.5M
 
Long-Term Debt $19.9M $44.5M $4.6M $4.7M --
Capital Leases -- -- -- -- --
Total Liabilities $51.9M $109.1M $112.2M $106.7M $82.6M
 
Common Stock $2.7M $3.4M $3.6M $3.7M $4.5M
Other Common Equity Adj -- -- -- -- --
Common Equity $70.2M $128.9M $71.9M $45.8M $92.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$670.3K -$683.9K -$411.8K -- --
Total Equity $69.5M $128.2M $71.5M $45.8M $92.2M
 
Total Liabilities and Equity $121.4M $237.3M $183.7M $152.4M $174.8M
Cash and Short Terms $93.3M $212.3M $101.6M $131.5M $155.5M
Total Debt -- $49.9M $7.3M $4.7M $4.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $93.3M $212.3M $101.6M $131.5M $155.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $4.2M $3.6M $2.6M $876.6K $2.5M
Other Current Assets -- -- -- -- --
Total Current Assets $98.4M $216.8M $165.6M $133.7M $160.1M
 
Property Plant And Equipment $22.9M $19.8M $17.4M $18.7M $14.7M
Long-Term Investments $131.6K $712.2K $666K -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $121.4M $237.3M $183.7M $152.4M $174.8M
 
Accounts Payable $271.8K $216.3K $420.4K $1.7M $16.7K
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $1.4M $5.4M $2.7M -- $4.8M
Current Portion Of Capital Lease Obligations $1.5M $1.7M $1.5M $1.8M $1.6M
Other Current Liabilities $8.6M $16.7M $10.7M $9.7M $9.7M
Total Current Liabilities $12.7M $31.2M $22.5M $37.8M $40.5M
 
Long-Term Debt $19.9M $44.5M $4.6M $4.7M --
Capital Leases -- -- -- -- --
Total Liabilities $51.9M $109.1M $112.2M $106.7M $82.6M
 
Common Stock $2.7M $3.4M $3.6M $3.7M $4.5M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$670.3K -$683.9K -$411.8K -- --
Total Equity $69.5M $128.2M $71.5M $45.8M $92.2M
 
Total Liabilities and Equity $121.4M $237.3M $183.7M $152.4M $174.8M
Cash and Short Terms $93.3M $212.3M $101.6M $131.5M $155.5M
Total Debt -- $49.9M $7.3M $4.7M $4.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$53.2M -$71.9M -$67.7M -$30M -$30M
Depreciation & Amoritzation $2.7M $2.8M $2.7M $2.7M $3M
Stock-Based Compensation $9M $7.4M $3M $3.4M $2.8M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$53.7M -$30.8M -$72.2M $23.3M -$39.4M
 
Capital Expenditures -- $572.7K $746.7K $1.5M $1.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1M -$502.9K -$740.3K $4.6M -$4.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $16.4M $32.7M -- -- --
Long-Term Debt Repaid -$690.9K -$970.2K -$47.5M -$2.8M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $16.6M $161.9M -$32.6M -$2.5M $76.1M
 
Beginning Cash (CF) $127.8M $89.7M $197.8M $102.6M $128.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$38.2M $130.6M -$105.6M $25.5M $32.3M
Ending Cash (CF) $86.6M $221.9M $99.9M $128.7M $161.7M
 
Levered Free Cash Flow -$54.8M -$31.3M -$73M $21.8M -$40.9M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$14.2M -$20.7M -$16.4M -$5.8M -$9.7M
Depreciation & Amoritzation $698K $660.4K $872.6K $777.1K $689.8K
Stock-Based Compensation $1.5M $2.1M -$254.4K $854K $580.3K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$12.5M $4.4M -$21.2M -$5.9M -$9.6M
 
Capital Expenditures -- $267.3K $20.3K $647K $121.5K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$112.7K -$197.5K -$14K $5.4M -$3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$102.2K $31.7M -- -- --
Long-Term Debt Repaid -$57.1K -$266.3K -$2.5M -$1.4M -$250.6K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$166.6K $32.3M $12.4M -$1.2M $77.3M
 
Beginning Cash (CF) $103.9M $184.1M $101.2M $131.3M $98.3M
Foreign Exchange Rate Adjustment -$1.5M $972.2K -$1.3M -$235.6K $772.4K
Additions / Reductions -$12.7M $36.5M -$8.8M -$1.7M $64.7M
Ending Cash (CF) $86.6M $221.9M $99.9M $128.7M $161.7M
 
Levered Free Cash Flow -$12.6M $4.1M -$21.2M -$6.6M -$9.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$53.2M -$71.9M -$67.7M -$30M -$30M
Depreciation & Amoritzation $2.7M $2.8M $2.7M $2.7M $3M
Stock-Based Compensation $9M $7.4M $3M $3.4M $2.8M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$53.7M -$30.8M -$72.2M $23.3M -$39.4M
 
Capital Expenditures -- $534.1K $746.7K $1.5M $1.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1M -$502.9K -$740.3K $4.6M -$4.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $16.4M $32.7M -- -- --
Long-Term Debt Repaid -$690.9K -$970.2K -$47.5M -$2.8M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $16.6M $161.9M -$32.6M -$2.5M $76.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$38.2M $130.6M -$105.6M $25.5M $32.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$54.8M -$31.3M -$73M $21.8M -$40.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$71.9M -$67.7M -$30M -$30M --
Depreciation & Amoritzation $2.8M $2.7M $2.7M $3M --
Stock-Based Compensation $7.4M $3M $3.4M $2.8M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$30.8M -$72.2M $23.3M -$39.4M --
 
Capital Expenditures $534.1K $746.7K $1.5M $1.5M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$502.9K -$740.3K $4.6M -$4.4M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $32.7M -- -- -- --
Long-Term Debt Repaid -$970.2K -$47.5M -$2.8M -$1.7M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $161.9M -$32.6M -$2.5M $76.1M --
 
Beginning Cash (CF) $525.3M $666.3M $522.5M $405.6M --
Foreign Exchange Rate Adjustment $1.5M $7.8M $648.5K $728.4K --
Additions / Reductions $130.6M -$105.6M $25.5M $32.3M --
Ending Cash (CF) $655.8M $555.8M $549.5M $438.2M --
 
Levered Free Cash Flow -$31.3M -$73M $21.8M -$40.9M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is up 109.21% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 14.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock